Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$39.40
-0.09-0.23%
Last update: Oct 14, 11:34 AM
Enliven Therapeutics Inc
ELVNNASDAQ
Market sentiment signals for Enliven Therapeutics (ELVN): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
13 analysts
Options Flow (P/C)
—
Avg Consensus PT
$66
+67.3%
Highest Price Target
$82
+108.1%
Lowest Price Target
$27
-31.5%
Short Interest
21.1%
Rising — Bearish
Insider Activity (30d)
Net Seller
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Oct 2, 2026 | Morgan Stanley | Sean Laaman— | +77.7% | $70 | Initiate | Overweight |
| Oct 1, 2026 | JP Morgan | Priyanka Grover— | +90.4% | $75 | Initiate | Overweight |
